CORE ONCOLOGY OÜ - 14508222 | ScoreStorybook | Print Summary Report

keywords

  • ärinõustamine

Employees and salaries

CORE ONCOLOGY OÜ

Number of employees and estimated average salaries
?

CORE ONCOLOGY OÜ

Employee taxes and performance analysis
?
QuarterLabor taxes
paid
Number of employees
Turnover
Per Employee
Profit
per employee
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................

Deciders and beneficiaries

CORE ONCOLOGY OÜ

Former deciders
?
Richard Robert Rowling
★★★★

......

Credit Score: None

Reputation scores: None

Date of birth: ......

Active relations 0

Richard Robert Rowling
★★★★

......

Credit Score: None

Reputation scores: None

Date of birth: ......

Active relations 0

Urmo Pärg
★★★★

......

Credit Score: Risky

Reputation scores: 460

Date of birth: ......

Active relations 2

CORE ONCOLOGY OÜ

Owners
?

Former owners

Former owners

NameCredit ScorePaymentBeginningEnd
!
..................

CORE ONCOLOGY OÜ

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
0.01
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnd
0.01
..................

Finances and assets

CORE ONCOLOGY OÜ

Paid taxes and estimated average salaries

CORE ONCOLOGY OÜ

Quarterly indicators
QuarterTurnoverTurnoverLabor productivityLabor productivityEmployeesNational taxesLabor taxes
2023 I ............ ..............................
2022 IV ............ ..............................
2022 III ............ ..............................
2022 II ............ ..............................
2022 I ............ ..............................
2021 IV ............ ..............................
2021 III ............ ..............................
2021 II ............ ..............................
2021 I ............ ..............................
2020 IV ............ ..............................
2020 III ............ ..............................
2020 II ............ ..............................
2020 I ............ ..............................
2019 IV ............ ..............................
2019 III ............ ..............................
2019 II ............ ..............................
2019 I ............ ..............................
2018 IV ............ ..............................
2018 III ............ ..............................
2018 II ............ ..............................

CORE ONCOLOGY OÜ

Sales revenue by business area

CORE ONCOLOGY OÜ

Financial indicators and prognosis

CORE ONCOLOGY OÜ

Financial raiting: "SATISFACTORY" (2023 prognosis)
2023 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

CORE ONCOLOGY OÜ

Annual reports
Year Period Submitted Report PDF
2022 01.01.2022–31.12.2022 15.03.2023 ......
2021 01.01.2021–31.12.2021 04.02.2022 ......
2020 01.01.2020–31.12.2020 26.02.2021 ......
2019 01.01.2019–31.12.2019 20.04.2020 ......
2018 01.01.2018–31.12.2018 19.03.2019 ......

Liabilities and debts

CORE ONCOLOGY OÜ

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

CORE ONCOLOGY OÜ

Reports and assets-liabilities overview 03.07.2023
?
Annual reports: ......
Annual reports: ......
Tax declarations:......

Assets to cover liabilities (short term)
Assets: ...... €1 EURO asset to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

CORE ONCOLOGY OÜ

Claims history
?
1 month
6 months
1 year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Debt claims ...... €

Total debt claims: ...... €

Latest events
...... ......

CORE ONCOLOGY OÜ

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTurnoverNational taxes paidLabor taxes paidNumber of employees
2023 I ...... €...... €...... €...... €......
2022 IV ...... €...... €...... €...... €......
2022 III ...... €...... €...... €...... €......
2022 II ...... €...... €...... €...... €......
2022 I ...... €...... €...... €...... €......
2021 IV ...... €...... €...... €...... €......
2021 III ...... €...... €...... €...... €......
2021 II ...... €...... €...... €...... €......
2021 I ...... €...... €...... €...... €......
2020 IV ...... €...... €...... €...... €......
2020 III ...... €...... €...... €...... €......
2020 II ...... €...... €...... €...... €......
2020 I ...... €...... €...... €...... €......
2019 IV ...... €...... €...... €...... €......
2019 III ...... €...... €...... €...... €......
2019 II ...... €...... €...... €...... €......
2019 I ...... €...... €...... €...... €......
2018 IV ...... €...... €...... €...... €......
2018 III ...... €...... €...... €...... €......
2018 II ...... €...... €...... €...... €......

CORE ONCOLOGY OÜ

Bailiff's enforcement proceedings as of 03.07.2023
?

Bailiff's enforcement proceedings MISSING

CORE ONCOLOGY OÜ

Regulations of the Payment Order Department as of 03.07.2023
?

Regulations of the Payment Order Department MISSING

CORE ONCOLOGY OÜ

Court orders in the register as of 03.07.2023
?
Logo

Puuduste kõrvaldamise määrus

26.06.2023

Regulation number: Ä 50096306 / M1

Regulation status has entered into force: 29.06.2023

Date of enforcement of order or additional period: 03.07.2023

Määruse olek: Puudused kõrvaldatud


CORE ONCOLOGY OÜ

Decisions of the Consumer Disputes Committee as of 03.07.2023
?

Consumer disputes MISSING

CORE ONCOLOGY OÜ

Court hearings as of 03.07.2023
?

Court hearings MISSING

CORE ONCOLOGY OÜ

Rulings as of 03.07.2023
?

Court settlemets MISSING

CORE ONCOLOGY OÜ

Notices and announcements as of 03.07.2023
?
Logo

Notice of liquidation proceedings of a private limited company

11.11.2022
Osaühingu likvideerimismenetluse teade
Avaldamise algus: 11.11.2022
Avaldamise lõpp: tähtajatu
Core Oncology OÜ (registrikood 14508222) (likvideerimisel) likvideerija avaldab teadaande äriseadustiku (ÄS) § 212 lõike 1 alusel.

Võlausaldajatele teatatakse Core Oncology OÜ (likvideerimisel) likvideerimismenetlusest.

Võlausaldajatel palume esitada oma nõuded nelja kuu jooksul käesoleva teate avaldamisest (ÄS § 212 lg 3). rrowling@core-oncology.com

Richard Robert Rowling
Core Oncology OÜ
Lasnamäe linnaosa, Tallinn, Harju maakond, Sepapaja tn 6
E-post: rrowling@core-oncology.com
Teadaande number 2000297

Marketing

Business network

CORE ONCOLOGY OÜ

Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

CORE ONCOLOGY OÜ

Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events were found

Failed to load monitoring events